Helios Technologies (HLIO) grants RSUs, performance options to executive

Rhea-AI Filing Summary

Martich Frederick Joseph reported acquisition or exercise transactions in this Form 4 filing.

Helios Technologies executive Frederick Joseph Martich received new equity awards. He was granted 2,807 restricted stock units, each representing one future share of common stock after vesting. These RSUs vest in three equal installments on January 3 of 2027, 2028, and 2029.

He was also granted 5,808 performance stock options, which provide the right to receive up to 225% of that number depending on pre-established performance metrics over a three-year period from the fiscal year 2026 through 2028. The options require continued employment through March 15, 2029 and will expire 10 years from the grant date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Martich Frederick Joseph

(Last) (First) (Middle)

C/O HELIOS TECHNOLOGIES, INC.

7456 16TH ST E

(Street)

SARASOTA FL 34243

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HELIOS TECHNOLOGIES, INC. [ HLIO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres. of Hydraulics, MCT

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	03/05/2026		A		2,807		(1)	(1)	Common Stock	2,807	$0	2,807	D
Performance Stock Options (right to buy)	$67.61	03/05/2026		A		5,808		(2)	(2)	Common Stock	5,808	$0	5,808	D

Explanation of Responses:

1. Each RSU represents the right to receive, following vesting, one share of Common Stock. Unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of January 3, 2027, January 3, 2028, and January 3, 2029.

2. The performance stock options granted to the reporting person on March 5, 2026, represent the right to receive, following vesting, a number of stock options up to 225% of the number of stock options. The number of performance stock options acquired upon vesting is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the fiscal year of 2026 and ending the last day of the fiscal year of 2028, subject to continuous employment with the Company through March 15, 2029. Stock options expire 10 years from the date of grant.

	/s/ Marc Greenberg, Attorney-in-fact for Frederick Joseph Martich	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did HLIO executive Frederick Martich report?

He reported equity awards, not open-market trades. Frederick Martich received 2,807 restricted stock units and 5,808 performance stock options, all as direct holdings. These awards increase his potential future ownership in Helios Technologies based on time-based vesting and performance conditions.

How do the new RSUs granted to the HLIO executive vest?

The 2,807 restricted stock units vest in three equal tranches. One-third converts into common stock on January 3, 2027, another third on January 3, 2028, and the final third on January 3, 2029, assuming the awards are not forfeited.

What are the terms of the performance stock options granted by Helios Technologies (HLIO)?

The 5,808 performance stock options can result in up to 225% of that number vesting. Actual options earned depend on pre-approved performance metrics for fiscal years 2026–2028, with continuous employment required through March 15, 2029, and a 10-year expiration from the March 5, 2026 grant date.

Are the HLIO insider’s new equity awards tied to performance targets?

Yes, the performance stock options are contingent on achieving pre-established performance metrics over a three-year period covering fiscal 2026 to 2028. The number of options ultimately acquired can be up to 225% of the initial 5,808, as approved by the company’s Compensation Committee.

Does the HLIO executive pay anything for these RSUs and options at grant?

The awards were granted at a stated price of $0.0000 per unit or option at grant, indicating they are compensation awards rather than purchases. Any future cost, such as an exercise price on options, is not detailed in the provided information.

What employment conditions apply to the HLIO performance stock options?

To receive performance stock options upon vesting, the executive must remain continuously employed with Helios Technologies through March 15, 2029. In addition to this service requirement, vesting also depends on meeting pre-established performance metrics over the fiscal 2026–2028 performance period.